This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Electrical Stimulation in Peripheral Arterial Disease (PAD)

This study has been terminated.
(Member of staff moved on to training post. Trial halted and terminated)
Sponsor:
Information provided by (Responsible Party):
Imperial College London
ClinicalTrials.gov Identifier:
NCT02136537
First received: May 9, 2014
Last updated: April 14, 2016
Last verified: November 2015
  Purpose
The investigators wish to investigate the effects of neuromuscular stimulation on intermittent claudication.

Condition Intervention
Peripheral Arterial Disease Device: Bilateral NMES legs Other: Best medical therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Electrical Stimulation in Peripheral Arterial Disease

Resource links provided by NLM:


Further study details as provided by Imperial College London:

Primary Outcome Measures:
  • Absolute walking distance [ Time Frame: 6 weeks ]
    Treadmill test (2mph, 0% grade increased by 3.5% every 3 minutes to a maximum of 15%


Secondary Outcome Measures:
  • Claudication distance [ Time Frame: 6 weeks ]
    Treadmill test (as per absolute walking distance)


Enrollment: 40
Study Start Date: August 2014
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Best medical therapy
Claudicants treated according to local protocol - no added treatment
Other: Best medical therapy
Treated according to local NHS protocol. At Imperial College Healthcare Trust, this will include diagnostic tests (medical interview and examination, ultrasound of blood vessels, diagnostic treadmill test, blood tests and Xrays as appropriate). This also includes lifestyle advice, treatment with appropriate drugs such as aspirin and statins, and supervised exercise.
Experimental: Best medical therapy plus NMES
In addition to best medical therapy, subjects will receive bilateral neuromuscular stimulation of their legs, 4 hours per day.
Device: Bilateral NMES legs
Stimulation with the geko(TM) device, Firstkind Ltd, UK. 4 hours per day, bilateral, applied to the skin overlying the common peroneal nerve
Other: Best medical therapy
Treated according to local NHS protocol. At Imperial College Healthcare Trust, this will include diagnostic tests (medical interview and examination, ultrasound of blood vessels, diagnostic treadmill test, blood tests and Xrays as appropriate). This also includes lifestyle advice, treatment with appropriate drugs such as aspirin and statins, and supervised exercise.

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of stable intermittent claudication (>6 months) with confirmation by medical imaging
  • ABPI<0.9
  • Absolute walking distance <500m

Exclusion Criteria:

  • Pregnancy
  • Cardiac pacemaker
  • Previous lower limb major amputation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02136537

Locations
United Kingdom
Charing Cross Hospital
London, United Kingdom
Sponsors and Collaborators
Imperial College London
Investigators
Principal Investigator: AH Davies Imperial College London
  More Information

Responsible Party: Imperial College London
ClinicalTrials.gov Identifier: NCT02136537     History of Changes
Other Study ID Numbers: 14/LO/0854
14HH2054 ( Other Identifier: Imperial College JRCO )
Study First Received: May 9, 2014
Last Updated: April 14, 2016

Additional relevant MeSH terms:
Peripheral Arterial Disease
Peripheral Vascular Diseases
Atherosclerosis
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on June 23, 2017